“Response to Ibrutinib of a Refractory IgA Lymphoplasmacytic Lymphoma Carrying the MYD88 L265P Gene Mutation”. Mediterranean Journal of Hematology and Infectious Diseases 11, no. 1 (August 29, 2019): e2019057. Accessed May 1, 2026. https://www.mjhid.org/mjhid/article/view/2019.057.